CD14 C-159T and early infection with Pseudomonas aeruginosa in children with cystic fibrosis

Respiratory Research

Volumn 6, Issue , 2005, Pages

  Martin, Andrew C ^a,c   Laing, Ingrid A ^a   Zhang, G ^a   Brennan, Shivs ^b   Winfield, Kayew ^b   Sly, Peters D ^b,c   Stick, Stephen M ^c   Goldblatt, Jack ^a   LeSouef, Peter N ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

CD14; Cystic fibrosis; Pseudomonas aeruginosa

Indexed keywords

CD14 ANTIGEN;

ARTICLE; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GRAM NEGATIVE INFECTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFANT; INFECTION RISK; LUNG LAVAGE; MALE; NONHUMAN; PROGNOSIS; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; AUSTRALIA; COHORT ANALYSIS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; INCIDENCE; NUCLEOTIDE SEQUENCE; PNEUMONIA, BACTERIAL; PROCEDURES; PSEUDOMONAS INFECTIONS; RISK ASSESSMENT; RISK FACTOR;

ANTIGENS, CD14; AUSTRALIA; CHILD; COHORT STUDIES; COMORBIDITY; CYSTIC FIBROSIS; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INCIDENCE; MALE; PNEUMONIA, BACTERIAL; PROGNOSIS; PSEUDOMONAS INFECTIONS; RISK ASSESSMENT; RISK FACTORS;

EID: 26244433173     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-6-63     Document Type: Article

References (7)

1. Accurso FJ, Sontag MK: Seeking modifier genes in cystic fibrosis. Am J Respir Crit Care Med 2003, 167:289-290.
2. Emerson J, Rosenfeld M, McNamara S, et al.: Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatric Pulmonology 2002, 34:91-100.
3. Baldini M, Lohman IC, Halonen M, et al.: A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999, 20:976-83.
4. Alexis N, Eldridge M, Reed W, et al.: CD14-dependent airway neutrophil response to inhaled LPS: role of atopy. J Allergy Clin Immunol 2001, 107:31-35.
5. Frevert CW, Matute-Bello G, Skerrett SJ, et al.: Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. Journal of Immunology 2000, 164(10):5439-45.
6. Schroder NW, Schumann RR: Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005, 3:156-64.
7. Eisen DP, Minchinton RM: Impact of mannose-binding lectin on susceptibility to infectious disease. Clin Infect Dis 2003, 37:1496-1505.